Related Experiment Video
Updated: Jul 10, 2025

14:45
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.0K
Animal Models for the Study of Gaucher Disease
Or Cabasso1, Aparna Kuppuramalingam1, Lindsey Lelieveld2
1Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Ramat Aviv 69978, Israel.
International Journal of Molecular Sciences
|November 25, 2023
Summary
Gaucher disease (GD) involves the accumulation of glucosylceramide (GlcCer) due to a faulty GCase enzyme. This review explores animal models for understanding GD's complex mechanisms.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- Gaucher disease (GD) is a sphingolipidosis caused by mutations in the GBA1 gene, leading to deficient acid β-glucocerebrosidase (GCase) activity.
- Accumulation of glucosylceramide (GlcCer) and glucosylsphingosine (GlcSph) in lysosomes, particularly in macrophages, is a hallmark of GD.
- Misfolding of mutant GCase in the endoplasmic reticulum (ER) triggers ER stress and the unfolded protein response (UPR).
Purpose of the Study:
- To review animal models used for studying Gaucher disease.
- To elucidate the molecular and cellular mechanisms underlying GD pathogenesis.
- To understand the role of ER stress and UPR in GD.
Main Methods:
- Review of existing literature on Gaucher disease animal models.
- Analysis of studies investigating GCase enzyme function and protein trafficking.
- Examination of research on ER-associated degradation (ERAD) and unfolded protein response (UPR) in GD.
Main Results:
- Animal models recapitulate key features of GD, including GlcCer accumulation and GCase deficiency.
- Studies highlight the impact of GCase misfolding, ER stress, and ERAD on disease severity.
- GD exhibits significant clinical heterogeneity, with distinct neurological involvement in different types.
Conclusions:
- Animal models are crucial for dissecting the complex pathophysiology of Gaucher disease.
- Understanding ER stress and protein misfolding pathways offers therapeutic targets for GD.
- Further research using these models can improve diagnosis and treatment strategies for GD.

